
Evommune Inc (EVMN) P/E Ratio
P/E Ratio as of Mar 11, 2026: -10.50
Average-10.97
Median-10.77
Minimum-11.90
Maximum-10.50
-10.50
The P/E ratio for Evommune Inc (EVMN) is -10.50 as of Mar 11, 2026. This represents a increase of 1,079.78% compared to its 12-month average P/E ratio of -0.89. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Evommune Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Evommune Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Evommune Inc to industry peers.
Evommune Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Evommune Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Evommune Inc to industry peers.
Evommune Inc (EVMN) P/E Ratio Insights
See Evommune Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Evommune Inc (EVMN)
Order type
Buy in
Order amount
Est. shares
0 shares
Evommune Inc (EVMN) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|
Evommune Inc (EVMN) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -10.50 | — |
FAQs About Evommune Inc (EVMN) P/E ratio
The latest P/E ratio of Evommune Inc (EVMN) is -10.50, as of Mar 11, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Evommune Inc’s last 12-month average P/E ratio is -0.89, compared to its current P/E ratio of -10.50. This reflects a increase of 1,079.78%.
Evommune Inc’s current P/E ratio of -10.50 is higher than its last 12-month average P/E of -0.89. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Evommune Inc’s average P/E ratio over the last 3 years is -0.3. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Evommune Inc’s average P/E ratio over the last 5 years is -0.18. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.